Cholinesterase inhibitors, such as donepezil, galantamine, and rivastigmine, are currently widely used to treat the severe and prevalent neurological disorder, Alzheimer’s disease, which is characterized by loss of cholinergic neurons in the basal forebrain55,56. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.